Adaptive Biotechnologies vs NeuraLight
Adaptive Biotechnologies vs NeuraLight, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptive Biotechnologies is on 69/100 and NeuraLight on 56/100.
Where each one leads
Adaptive Biotechnologies
- our overall score: 69/100 against 56/100
- domain rating: 62/100 against 29/100
- funding raised: $300M against $43.0M
NeuraLight
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Adaptive Biotechnologies | NeuraLight |
|---|---|---|
| What it is | Leveraging the adaptive immune system to diagnose and treat disease. | AI-powered digital health company transforming neurology with oculometrics for diagnostics and clinical development. |
| Category | Biotech, HealthTech, Genomics, Drug Discovery | Neurology, Healthcare, Telehealth, Biomarkers |
| Sells toBusiness model | B2B | B2C |
| Offering | Software | services | platform | Software |
| Founded | 2009 | 2021 |
| Headquarters | Seattle, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Adaptive Biotechnologies | NeuraLight |
|---|---|---|
| Employees | Not published | 29 |
| Headcount growthLast 12 months | Not published | -11.2% |
| Total funding | $300M | $43.0M |
| Latest round | Series D | Seed |
| LinkedIn followers | Not published | 7,466 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adaptive Biotechnologies | NeuraLight |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 69/100 | 56/100 |
| Traction | Not published | 53/100 |
| Team | Not published | 70/100 |
| Search visibility | Not published | 32/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 62/100 | 29/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adaptive Biotechnologies | NeuraLight |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | Webflow |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager | Google Analytics 4, Linkedin Insight |
Adaptive Biotechnologies vs NeuraLight: common questions
Which is better, Adaptive Biotechnologies or NeuraLight?
On our 0-100 score Adaptive Biotechnologies rates higher (69/100 against 56/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Adaptive Biotechnologies and NeuraLight compare on the numbers?
Adaptive Biotechnologies leads on our overall score (69/100 against 56/100), domain rating (62/100 against 29/100), funding raised ($300M against $43.0M).
Read the full Adaptive Biotechnologies review and pricing or the NeuraLight review and pricing. You can also browse other Adaptive Biotechnologies alternatives we track.